Page last updated: 2024-08-24

irinotecan and Hemolysis

irinotecan has been researched along with Hemolysis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gholami, L; Jaafari, MR; Mahmoudi, A; Malaekeh-Nikouei, B; Ramezanian, N1
Bozzato, E; Lopes, A; Papavasileiou, M; Préat, V; Tsakiris, N; Vigneron, AM1

Other Studies

2 other study(ies) available for irinotecan and Hemolysis

ArticleYear
BR2 and CyLoP1 enhance in-vivo SN38 delivery using pegylated PAMAM dendrimers.
    International journal of pharmaceutics, 2019, Jun-10, Volume: 564

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Dendrimers; Drug Carriers; Drug Liberation; Erythrocytes; Female; Hemolysis; Humans; Irinotecan; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Oligopeptides; Polyethylene Glycols; Tissue Distribution

2019
Combinational drug-loaded lipid nanocapsules for the treatment of cancer.
    International journal of pharmaceutics, 2019, Oct-05, Volume: 569

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Combinations; Erythrocytes; Female; Hemolysis; Humans; Irinotecan; Lipids; Mice, Inbred BALB C; Nanocapsules; Neoplasms; Phenylurea Compounds; Pyridines

2019